O
Oncozenge AB
F:8LY
Oncozenge AB
F:8LY
Price:
0.661
EUR
3.93%
Market Closed
Market Cap:
€7.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oncozenge AB
F:8LY
|
SE |
|
Saga Communications Inc
F:SGHB
|
US |
|
A
|
Andlauer Healthcare Group Inc
F:3LT
|
CA |
|
C
|
CiDi Inc
HKEX:3881
|
CN |
Cash Flow Statement
Cash Flow Statement
Oncozenge AB
Oncozenge AB
Currency: SEK
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(5)
|
(36)
|
(38)
|
(40)
|
(44)
|
(15)
|
(16)
|
(17)
|
(16)
|
(14)
|
(12)
|
(9)
|
(9)
|
(6)
|
(7)
|
(9)
|
(16)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
23
|
23
|
23
|
23
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Change in Working Capital |
0
|
(2)
|
(4)
|
(3)
|
(2)
|
(3)
|
2
|
0
|
(1)
|
(0)
|
(1)
|
(2)
|
(0)
|
(2)
|
1
|
1
|
3
|
|
| Cash from Operating Activities |
(5)
N/A
|
(15)
-212%
|
(19)
-26%
|
(20)
-9%
|
(22)
-8%
|
(17)
+23%
|
(14)
+15%
|
(17)
-17%
|
(17)
-1%
|
(15)
+14%
|
(13)
+11%
|
(11)
+18%
|
(9)
+18%
|
(8)
+5%
|
(6)
+28%
|
(8)
-29%
|
(13)
-68%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Other Items |
(5)
|
(5)
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(5)
N/A
|
(5)
+11%
|
(4)
+22%
|
(2)
+35%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
60
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
8
|
|
| Other |
(9)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
|
| Cash from Financing Activities |
51
N/A
|
(4)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
14
N/A
|
13
-5%
|
|
| Change in Cash | ||||||||||||||||||
| Net Change in Cash |
41
N/A
|
(24)
N/A
|
(22)
+6%
|
(23)
-2%
|
(22)
+3%
|
(17)
+23%
|
(14)
+15%
|
(17)
-17%
|
(17)
+2%
|
(14)
+14%
|
(12)
+12%
|
(10)
+19%
|
(9)
+13%
|
(8)
+5%
|
(6)
+28%
|
6
N/A
|
(0)
N/A
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(5)
N/A
|
(15)
-212%
|
(19)
-26%
|
(20)
-9%
|
(22)
-8%
|
(17)
+23%
|
(14)
+15%
|
(17)
-17%
|
(17)
-1%
|
(15)
+14%
|
(13)
+11%
|
(11)
+18%
|
(9)
+18%
|
(8)
+5%
|
(6)
+28%
|
(8)
-29%
|
(13)
-68%
|
|
Switch to:
Switch to:
Continue 8LY Research
Other Oncozenge AB listings:
Discover More
